Surgery Partners

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Surgery Partners reports robust Q4 earnings, eyes growth in cardiac care

Surgery Partners' strong financial performance, driven by strategic initiatives and revenue growth, positions the company for continued success. While facing challenges in adoption rates and reimbursement, the company's focus on outpatient care and higher acuity service lines presents growth opportunities. With a proactive approach to recruitment and expansion, Surgery Partners is poised for a positive trajectory in 2023.

Surgery Partners (SGRY) posts robust Q1 results, eyes strategic growth

Surgery Partners (SGRY) delivered strong financial performance, operational efficiency, and strategic growth initiatives in Q1 2023.
Despite challenges from revenue timing and minimal earnings impact in the short term, the company's disciplined approach and focus on partnerships and acquisitions offer promising opportunities.
With a raised adjusted EBITDA outlook, a commitment to excellence, and a clear growth strategy, Surgery Partners is well-positioned for continued success and value creation.

Surgery Partners exceeds Q2 expectations, eyes strategic growth opportunities

Surgery Partners delivered strong financial performance in Q2 2023, surpassing expectations and demonstrating resilience in surgical case growth.
Despite challenges in anesthesia coverage and subsidies, the company remains optimistic about its growth prospects and is focused on operational efficiencies.
Strategic investments in orthopedics and cardiology, along with a commitment to high-quality care, underscore Surgery Partners' long-term growth potential.

Surgery Partners beats Q3 targets, eyes mid-teens growth in 2024

Surgery Partners exceeded Q3 expectations, showcasing strong performance and strategic initiatives. While facing challenges from portfolio adjustments and regulatory proposals, the company is well-positioned for continued growth through acquisitions and focus on high acuity cases.

Surgery Partners (SGRY) reports robust 2023 results and eyes strategic growth in 2024

Surgery Partners (SGRY) delivered strong financial performance in 2023, with a positive outlook for 2024. The company's focus on margin expansion, growth in higher acuity procedures, and strategic acquisitions positions it well for continued success. Challenges include cash flow uncertainties and the impact of unique comp dynamics on case growth.

Surgery Partners (SGRY) reports robust Q1 earnings and eyes strategic acquisitions for continued growth

Surgery Partners (SGRY) delivered strong financial results in Q1 2024, showcasing solid revenue growth and margin expansion. The company's strategic focus on acquisitions, margin improvement initiatives, and effective cost management underpin its optimistic outlook for sustained growth and cash flow generation.

Surgery Partners (SGRY) posts impressive Q2 results, raises full-year outlook

Surgery Partners (SGRY) delivered strong financial performance in Q2 2024, driven by revenue growth, enhanced margins, and strategic acquisitions. Despite facing leverage challenges, the company's focus on specialty physician recruitment and operational efficiency presents opportunities for sustained growth and profitability.

Surgery Partners posts strong Q3 results amidst Hurricane challenges

Surgery Partners demonstrated robust financial performance in Q3 2024, marked by revenue growth, margin expansion, and strategic acquisitions.
While facing challenges from Hurricane Helene, the company's focus on recruitment and growth in key specialties positions it well for future success.
With a strong outlook for the full year and a focus on high-growth markets and specialties, Surgery Partners shows resilience and strategic foresight.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene

HCA Healthcare

Humana

Tenet Healthcare

Universal Health Services

UnitedHealth Group

Recent growth in inpatient and outpatient services has been even higher than elevated investor expectations, Mizuho Securities analysts said in a research note Tuesday. Outpatient volume grew 8% in the second quarter, compared with the year-earlier period, while inpatient volume grew 4%, according to a Mizuho survey of more than 200 doctors in 14 specialties.

Healthcare demand outpacing investor expectations, boosting outlook for providers, Mizuho analysts say

Surgery Partners comes with a set of attractive investment criteria. SGRY's economic characteristics, such as a consistent stream of 20% returns on existing capital, are standout features in the debate. A revised growth outlook and attractive valuation support a buy rating with a $62.50 price target.

Surgery Partners: Exceptional Business Economics, Trading Below Fair Value

Boston Scientific

Elevance Health Inc

Intuitive Surgical

Smith & Nephew

Zimmer Biomet Hlds

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but potentially good business for surgery centers like Surgery Partners Inc. NASDAQ: SGRY and companies like Zimmer Biomet Holdings Inc. NYSE: ZBH that manufacture joint-replacement technologies.

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Strength Seen in Surgery Partners (SGRY): Can Its 5.0% Jump Turn into More Strength?

UNH stock slumped after management said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock racing past a buy point.

UnitedHealth's Bad News Hits Insurers, But Sparks Surgery Partners Breakout

Shares of hospital and surgical-center operators moved higher premarket on Wednesday after a UnitedHealth Group Inc. UNH executive commented Tuesday on a trend of older adults catching up on surgeries delayed during the pandemic. Shares of Surgery Partners Inc. SGRY, an operator of surgical facilities and related services, gained 4.9% premarket Wednesday, while shares of hospital operator Community Health Systems Inc. CYH gained 7.6% and shares of hospital giant HCA Healthcare Inc. HCA gained 2.2%.

Health insurers' pain means gains for hospital, surgical center stocks

Cigna

Community Health Systems

Seniors are finally catching up on surgery for problems with their knees and hips they delayed during the pandemic — and that means higher costs for health insurers.

Seniors are finally catching up on delayed surgeries. That's bad news for health insurers.

Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jason Cassorla - Citi Nabil Gutierrez - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Whit Mayo - SVB Securities Bill Sutherland - The Benchmark Company Stephen Valiquette - Barclays Operator Greetings, and welcome to the Surgery Partners First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode.

Surgery Partners, Inc. (SGRY) Q1 2023 Earnings Call Transcript

BRENTWOOD, Tenn., May 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the first quarter ended March 31, 2023.

Surgery Partners, Inc. Announces First Quarter 2023 Results

BRENTWOOD, Tenn., April 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2023 results after market close on Monday, May 1, 2023, to be followed by a conference call at 5:00 p.m. (Eastern Time)

Surgery Partners, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call Details

Surgery Partners, Inc. (NASDAQ:SGRY ) Q4 2022 Earnings Conference Call March 1, 2023 10:00 AM ET Company Participants Dave Doherty – Executive Vice President and Chief Financial Officer Wayne DeVeydt – Executive Chairman Eric Evans – Chief Executive Officer Conference Call Participants Ben Rossi – Citigroup Kevin Fischbeck – Bank of America Tao Qiu – Stifel Ben Hendrix – RBC Capital Markets Bill Sutherland – Benchmark Lisa Gill – JPMorgan Gary Taylor – Cowen and Company Whit Mayo – SVB Securities Brian Tanquilut – Jefferies Operator Greetings, and welcome to the Surgery Partners, Inc. Fourth Quarter 2022 Earnings Call. At this time all participants are in a listen-only mode.

Surgery Partners, Inc. (SGRY) Q4 2022 Earnings Call Transcript

Surgery Partners (SGRY) delivered earnings and revenue surprises of 28.57% and 2.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Q4 Earnings and Revenues Top Estimates

BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2022.

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance

Surgery Partners provides surgical services to patients across the US. The company's recent acquisition of National Surgical Healthcare presents an opportunity for further expansion and revenue growth.

Surgery Partners: Loss Making Yet A Promising Opportunity In The Surgical Services

BRENTWOOD, Tenn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2022 results before the market opens on Wednesday, March 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time).

Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 9, 2023, as part of the 41st Annual J.P. Morgan Healthcare Conference, including a presentation at 8:15 p.m. ET. Based on results through November 2022, the Company is re-affirming its 2022 Adjusted EBITDA guidance of $375 million to $385 million and its 2022 Revenue guidance of $2.50 billion to $2.55 billion.

Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance

BRENTWOOD, Tenn., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 9, 2023 at 8:15p.m. (Eastern Time).

Surgery Partners, Inc. To Present At Upcoming Investor Conference

Surgery Partners Inc (NASDAQ: SGRY) shares are trading lower by 8.06% to $25.09 after the company announced a $275M common stock offering. What Else?

Why Surgery Partners Stock Is Falling 8% Today - Surgery Partners (NASDAQ:SGRY)

BRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its upsized underwritten public offering of $575 million of its common stock at a public offering price of $24.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $575 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. In addition, Surgery Partners has granted the underwriters a 30-day option to purchase up to an additional $86.25 million of its common stock, at the public offering price less underwriting discounts and commissions. All of the shares in the offering are being sold by Surgery Partners. The offering is expected to close on or about November 23, 2022, subject to customary closing conditions.

Surgery Partners, Inc. Announces Pricing of Upsized $575 Million Public Offering of Common Stock and $225 Million Concurrent Private Placement to Bain Capital

Shares of Surgery Partners Inc. SGRY, +1.00% shed 2.6% in premarket trading Monday, after the outpatient health care services company said it launched a public offering of $275 million worth of its common stock. The offering represents 11.2% of the market capitalization of $2.45 billion as of Friday's close.

Surgery Partners stock falls after public stock offering of $275 million, private placement of $225 mln

BRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of $275 million of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to $41.25 million of additional shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock

Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Lisa Gill - JP Morgan Ben Hendrix - RBC Capital Operator Greetings, and welcome to the Surgery Partners, Inc. Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Surgery Partners Inc. (SGRY) Q3 2022 Earnings Call Transcript

Surgery Partners (SGRY) delivered earnings and revenue surprises of -150% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Reports Q3 Loss, Lags Revenue Estimates

BRENTWOOD, Tenn., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2022.

Surgery Partners, Inc. Announces Third Quarter 2022 Results

BRENTWOOD, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2022 results before the market opens on Tuesday, November 8, 2022, to be followed by a conference call at 8:30 a.m. (Eastern Time)

News for Surgery Partners Stock (SGRY)